Sort   by:  
 Page size 
UnknownTargeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells.
Not available
S-EPMC6414792 | biostudies-literature
UnknownGeneration and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization.
Not available
S-EPMC6362131 | biostudies-literature
UnknownBCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker.
Not available
S-EPMC6330761 | biostudies-literature
UnknownCombination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK.
Not available
S-EPMC4454319 | biostudies-literature
UnknownBiological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma.
Not available
S-EPMC4496181 | biostudies-literature
UnknownBCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival.
Not available
S-EPMC10393035 | biostudies-literature
UnknownDexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma.
Not available
S-EPMC4694963 | biostudies-literature
UnknownDual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes.
Not available
S-EPMC7200824 | biostudies-literature
UnknownThe Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma.
Not available
S-EPMC3887407 | biostudies-literature
UnknownRITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53abnormal myeloma cells independently of the p53 pathway.
Not available
S-EPMC4094448 | biostudies-literature
Sort   by:  
 Page size